Ipsen header image

Ipsen

IPN

Equity

ISIN FR0010259150 / Valor 2348805

Euronext - Euronext Paris (2026-07-31)
EUR 167.20+6.36%

Ipsen
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Ipsen is a France-based, research-driven biopharmaceutical company that develops, manufactures and commercializes specialty-care medicines with a focus on oncology, rare diseases and neuroscience. Its marketed portfolio includes treatments such as Somatuline (lanreotide) for neuroendocrine tumors and acromegaly, Decapeptyl (triptorelin) in endocrine and oncology indications, and Dysport (abobotulinumtoxinA) for certain neurological and aesthetic uses; the group builds its business through internal R&D, acquisitions and licensing partnerships to advance a pipeline of targeted and rare-disease therapies and to support global commercial operations across Europe, North America and Asia.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

61.2%1Y
45.9%3Y
85.6%5Y

Performance

27.3%1Y
25.1%3Y
27.8%5Y

Volatility

Market cap

15954 M

Market cap (USD)

Daily traded volume (Shares)

214,745

Daily traded volume (Shares)

1 day high/low

110.8 / 109.9

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

BioVersys AG
BioVersys AG BioVersys AG Valor: 21036264
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.92%CHF 26.60
Penumbra Inc
Penumbra Inc Penumbra Inc Valor: 29290920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.43%USD 321.19
Laboratorios Farmaceuticos Rovi, SA
Laboratorios Farmaceuticos Rovi, SA Laboratorios Farmaceuticos Rovi, SA Valor: 3591807
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%EUR 58.55
Coty Inc
Coty Inc Coty Inc Valor: 1645885
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.23%USD 2.75
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.31%USD 91.61
Icon PLC
Icon PLC Icon PLC Valor: 1017575
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.19%USD 163.56
Galenica Ltd.
Galenica Ltd. Galenica Ltd. Valor: 36067446
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.83%CHF 85.95
Envista Holdings Corporation
Envista Holdings Corporation Envista Holdings Corporation Valor: 49153522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.69%USD 27.31
Encompass Health Corporation
Encompass Health Corporation Encompass Health Corporation Valor: 39085960
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.16%USD 111.07
QuidelOrtho Corporation
QuidelOrtho Corporation QuidelOrtho Corporation Valor: 119356965
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%USD 16.77